Delivery Order SPE2DB24D1205-SPE2DB24FCRFW

Award Date 5/13/24
Potential Completion Date 5/14/24
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $14,004.50 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,565,094,188 units of the HAVRIX 1,440 unit/mL syringe medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical through December 31, 2025. The IDC allows the DLA to efficiently procure a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,567.92 firm fixed price delivery order to provide 4,563,580,840 units of the HAVRIX 720 0.5 ML syringe. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA...
This is a $1,027.23 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for HAVRIX 1,440 UNIT/ML syringes and has an ultimate completion date of April 17, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
The Defense Logistics Agency (DLA) awarded a $3,055.68 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product. This order falls under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $1,439.68 to supply Havrix 1,440 unit/mL syringes. This contract has a completion date of March 4, 2024 and was awarded on March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and the place of performance is Conshohocken, Pennsylvania. This delivery order is part of a larger indefinite...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply HAVRIX 720 unit/0.5 mL syringes. The $1,373.10 delivery order, which has a completion date of January 16, 2024, is part of the agency's efforts to provide pharmaceuticals and medical supplies to military treatment programs and facilities. AmerisourceBergen Drug Corp, as a prime...
This federal contract award, valued at $3,811.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of May 9, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $5,648.91 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This contract is for the provision of HAVRIX 1,440 Unit/mL syringes, a pharmaceutical product. The contract has a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order contract, which is part of a larger indefinite delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,181.66, is for the supply of HAVRIX 720 unit/0.5 mL syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is between the Defense Logistics Agency (DLA) and AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,905.50, is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML. It is a firm fixed-price delivery order that runs through February 26, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCRFW
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $1,110.72 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,440 units of HAVRIX 1,440 UNIT/ML SYRINGE medication. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense globally. The contract has a performance period through May 14, 2024 and does not include a set-aside designation.

Generated 8/12/24, 9:09 AM